Alan Anticevic, Ph.D.
In an effort to understand cortical dysfunction in schizophrenia, Alan is conducting research to test the hypothesis that disturbances in the cortical microcircuitry resulting from disruptions of the NMDA glutamate receptor may contribute to perceptual and cognitive disturbances in patients.
David Assis, M.D.
David is conducting research to determine whether macrophage migration inhibitory factor (MIF) polymorphisms and the relationship of MIF to its receptor CD74 play a role in the pathophysiology of autoimmune hepatitis.
E. Jennifer Edelman, M.D., M.H.S.
Jennifer is studying the immunosuppressive effects of prescription opioids among HIV-infected patients who are often prescribed these drugs, with the goal of developing interventions to promote safer opioid prescribing in these patients.
Aileen Gariepy, M.D., M.P.H.
Aileen is investigating the relationship between pregnancy intention, depression, and preterm birth in order to develop new interventions and prevention strategies that mitigate the risk of preterm birth.
Lucia Jilaveanu, M.D., Ph.D.
Lucia is conducting research on the mediators of brain metastases in metastatic melanoma that involves screening a number of candidate genes upregulated in specimens from patients with early brain metastases, and developing a biomarker model that predicts metastasis to the brain.
Christoph Juchem, Ph.D.
Christoph is conducting a study that applies magnetic resonance spectroscopic imaging (MRSI) methods to quantify and detect glutathione and other neurochemicals in the brain, in order to better understand the role of neuroprotection in multiple sclerosis.
Kasia Lipska, M.D., M.H.S.
Kasia is conducting a study to examine severe hypoglycemia occurring in the course of type 2 diabetes treatment, particularly in older patients, in order to help guide the design of interventions to mitigate the risk.
Hanna Stevens, M.D., Ph.D.
Jeffrey Testani, M.D., M.T.R.
Bingqing Zhou, Ph.D.
Bingqing is working on a project to develop novel competing risks methodology to estimate more accurately the risks of graft failure and death following kidney transplantation, in order to optimize the process of kidney allocation and improve post-transplantation management.
Jiangbing Zhou, Ph.D.
Jiangbing is working on a project to synthesize tumor-responsive nanoparticles for systemic drug delivery to brain tumors, and to evaluate the therapeutic effects of novel drugs targeting brain cancer stem cells in order to develop new treatment options for glioblastoma multiforme.